医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Asahi Kasei Medical to Double Production Capacity for Planova™ BioEX Filters

2021年07月14日 AM11:00
このエントリーをはてなブックマークに追加


 

TOKYO

Asahi Kasei Medical has decided to expand production capacity of hydrophilic PVDF (polyvinylidene fluoride) hollow-fiber membranes for Planova™ BioEX filters at its spinning plant in Oita, Japan. The global COVID-19 pandemic has increased the urgent demand for Planova™ filters, which are indispensable to develop and mass-produce anti-coronavirus agents. Asahi Kasei Medical will double spinning production capacity at this site by utilizing its state-of-the-art technology. The capacity increase is expected to commence in the fourth quarter of calendar year 2022.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210713005600/en/

Planova™ virus removal filters (Photo: Business Wire)

Planova™ virus removal filters (Photo: Business Wire)

As for the Planova™ N series filters made with cellulose hollow-fiber membranes, all six existing plants, including the spinning plant completed in 2019 in Miyazaki, Japan, have been operating efficiently and without any disruption to meet the increasing demand worldwide.

Asahi Kasei Medical is the global market leader in virus filtration, with its Planova™ filters having an unrivaled 30-year history of trusted use in the production of biotherapeutics. Asahi Kasei Medical aims to provide “Assurance Beyond Expectation” in the form of innovative yet exceptionally reliable bioprocess consumables, equipment, scientific support, and biosafety testing services to help biologics manufacturers safely and efficiently produce medicines that patients can trust.

Asahi Kasei Medical will continue to reinforce its global supply infrastructure for Planova™ through proactive investments in manufacturing facilities in order to support the early provision of vaccines and life-saving therapies to as many people as possible.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210713005600/en/

CONTACT

For more information, please contact:

Ryo Kobayashi

Corporate Communications

Asahi Kasei Corp.

Phone: +81-(0)3-6699-3008

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Synaffix宣布与普方生物达成价值2.46亿美元的ADC合作
  • Aurion Biotech Announces IOTA Cell Therapy Trial
  • rf IDEAS将在HIMSS21展会上展示与医疗合作伙伴的合作成果
  • rfアイデアズがHIMSS21でヘルスケアパートナーとの協業を紹介
  • Kyowa Kirin Provides Update on Application for Marketing Authorisation of Istradefylline in Europe for the Treatment of ‘OFF’ Episodes in People Living with Parkinson’s